Fulc investors have opportunity to lead fulcrum therapeutics, inc. securities fraud lawsuit

Los angeles , june 9, 2023 /prnewswire/ -- the law offices of frank r. cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against fulcrum therapeutics, inc. ("fulcrum" or the "company") (nasdaq: fulc).
FULC Ratings Summary
FULC Quant Ranking